Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
chidamide
Description:
Chidamide, also called tucidinostat, is a histone deacetylase inhibitor studied as an anticancer drug.
Primary topic:
Lymphoma Diagnosis and Treatment (30%)
Related topics:
Lymphoma Diagnosis and Treatment (30%),
Acute Myeloid Leukemia Research (15%),
Histone Deacetylase Inhibitors Research (15%)
Wikidata ID:
wiki/Q19903814
OpenAlex ID:
keywords/chidamide
Results from a multicenter, open-label, pivotal phase II study of chidamide in relapsed or refractory peripheral T-cell lymphoma
2015
·
Y. Shi
, M. Dong
, et al.
·
Annals of Oncology
·
454
Chidamide (CS055/HBI-8000): a new histone deacetylase inhibitor of the benzamide class with antitumor activity and the ability to enhance immune cell-mediated tumor cell cytotoxicity
2011
·
Zhi-Qiang Ning
, Zhi-Bin Li
, et al.
·
Cancer Chemotherapy and Pharmacology
·
320
Tucidinostat plus exemestane for postmenopausal patients with advanced, hormone receptor-positive breast cancer (ACE): a randomised, double-blind, placebo-controlled, phase 3 trial
2019
·
Zefei Jiang
, Wei Li
, et al.
·
The Lancet Oncology
·
287
Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China
2017
·
Yuankai Shi
, Bo Jia
, et al.
·
Journal of Hematology & Oncology
·
264
PDF
Safety and Tolerability of Histone Deacetylase (HDAC) Inhibitors in Oncology
2019
·
Rashmi R. Shah
·
Drug Safety
·
211
Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trial
2024
·
Feng Wang
, Ying Jin
, et al.
·
Nature Medicine
·
210
Development of chidamide for peripheral T-cell lymphoma, the first orphan drug approved in China
2016
·
Xianping Lu
, Zhiqiang Ning
, et al.
·
Intractable & Rare Diseases Research
·
191
PDF
CS055 (Chidamide/HBI-8000), a novel histone deacetylase inhibitor, induces G1 arrest, ROS-dependent apoptosis and differentiation in human leukaemia cells
2012
·
Ke Gong
, Jia Xie
, et al.
·
Biochemical Journal
·
134
Phase I study of chidamide (CS055/HBI-8000), a new histone deacetylase inhibitor, in patients with advanced solid tumors and lymphomas
2012
·
Mei Dong
, Zhi-Qiang Ning
, et al.
·
Cancer Chemotherapy and Pharmacology
·
128
Frequent amplification of HDAC genes and efficacy of HDAC inhibitor chidamide and PD-1 blockade combination in soft tissue sarcoma
2021
·
Yi Que
, Xiao-Long Zhang
, et al.
·
Journal for ImmunoTherapy of Cancer
·
112
PDF
Novel HDAC inhibitor Chidamide synergizes with Rituximab to inhibit diffuse large B-cell lymphoma tumour growth by upregulating CD20
2020
·
Xu-Wen Guan
, Hua-Qing Wang
, et al.
·
Cell Death and Disease
·
104
PDF
Histone modifier gene mutations in peripheral T-cell lymphoma not otherwise specified
2018
·
Meng-Meng Ji
, Yao-Hui Huang
, et al.
·
Haematologica
·
104
Class I HDAC inhibitors enhance antitumor efficacy and persistence of CAR-T cells by activation of the Wnt pathway
2024
·
Meng Zhu
, Yingli Han
, et al.
·
Cell Reports
·
98
Therapeutic potential of tucidinostat, a subtype-selective HDAC inhibitor, in cancer treatment
2022
·
Yichen Sun
, Jing Han Hong
, et al.
·
Frontiers in Pharmacology
·
97
PDF
The Long Noncoding RNA MEG3 and its Target miR-147 Regulate JAK/STAT Pathway in Advanced Chronic Myeloid Leukemia
2018
·
Zi-ye Li
, Lin Yang
, et al.
·
EBioMedicine
·
87
PDF
Increased PRAME-Specific CTL Killing of Acute Myeloid Leukemia Cells by Either a Novel Histone Deacetylase Inhibitor Chidamide Alone or Combined Treatment with Decitabine
2013
·
Yushi Yao
, Jihao Zhou
, et al.
·
PLoS ONE
·
84
PDF
Zinc-dependent Deacetylase (HDAC) Inhibitors with Different Zinc Binding Groups
2019
·
Yan Li
, Fang Wang
, et al.
·
Current Topics in Medicinal Chemistry
·
80
Chidamide, a novel histone deacetylase inhibitor, synergistically enhances gemcitabine cytotoxicity in pancreatic cancer cells
2013
·
Zhixin Qiao
, Suping Ren
, et al.
·
Biochemical and Biophysical Research Communications
·
80
Chidamide in the treatment of peripheral T-cell lymphoma
2017
·
Thomas Chan
, Eric Tse
, et al.
·
OncoTargets and Therapy
·
79
PDF
A novel histone deacetylase inhibitor Chidamide induces apoptosis of human colon cancer cells
2010
·
Lin Liu
, Baoan Chen
, et al.
·
Biochemical and Biophysical Research Communications
·
79
Chidamide, a novel histone deacetylase inhibitor, inhibits the viability of MDS and AML cells by suppressing JAK2/STAT3 signaling.
2016
·
Sida Zhao
, Juan Guo
, et al.
·
Europe PMC (PubMed Central)
·
77
Non-toxic dose chidamide synergistically enhances platinum-induced DNA damage responses and apoptosis in Non-Small-Cell lung cancer cells
2014
·
You Zhou
, De-Si Pan
, et al.
·
Biomedicine & Pharmacotherapy
·
77
Efficacy and safety of novel multifunctional M10 CAR-T cells in HIV-1-infected patients: a phase I, multicenter, single-arm, open-label study
2024
·
Yunyu Mao
, Qibin Liao
, et al.
·
Cell Discovery
·
74
Chidamide increases the sensitivity of Non-small Cell Lung Cancer to Crizotinib by decreasing c- MET mRNA methylation
2020
·
Nan Ding
, Abin You
, et al.
·
International Journal of Biological Sciences
·
74
PDF
Cooperative effect of chidamide and chemotherapeutic drugs induce apoptosis by DNA damage accumulation and repair defects in acute myeloid leukemia stem and progenitor cells
2017
·
Yin Li
, Yan Wang
, et al.
·
Clinical Epigenetics
·
73
PDF
Show more works
View as search
Works count:
904
Citation count:
9,604
Year
Topic
Type